Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
LAW OFFICE OF SALVATORE ARRIGO
WASHINGTON, DC US
1. 20110020908 MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMA VIRUSES 01-27-20112. 20110014242 PROMOTERS FOR EXPRESSION IN MODIFIED VACCINIA VIRUS ANKARA 01-20-2011
3. 20110014234 MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMA VIRUSES 01-20-2011
4. 20110008792 PROMOTERS FOR EXPRESSION IN MODIFIED VACCINIA VIRUS ANKARA 01-13-2011
5. 20100316671 MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES 12-16-2010
6. 20100303856 INTERGENIC REGIONS AS INSERTION SITES IN THE GENOME OF MODIFIED VACCINIA VIRUS ANKARA (MVA) 12-02-2010
7. 20100291139 RECOMBINANT MVA VIRUS AND THE USE THEREOF 11-18-2010
8. 20100285071 PURIFICATION OF HER-2 VARIANTS - for a novel method for purification of EGFR family proteins obtained from cultures of insect cells 11-11-2010
9. 20100279386 MODIFIED VACCINIA ANKARA VIRUS VARIANT AND CULTIVATION METHOD 11-04-2010
10. 20100266630 Recombinant MVA virus, and the use thereof 10-21-2010
11. 20100233203 OPTIMIZED EARLY-LATE PROMOTER COMBINED WITH REPEATED VACCINATION FAVORS CYTOTOXIC T CELL RESPONSE AGAINST RECOMBINANT ANTIGEN IN MVA VACCINES 09-16-2010
12. 20100196992 INTERGENIC REGIONS AS NOVEL SITES FOR INSERTION OF HIV DNA SEQUENCES IN THE GENOME OF MODIFIED VACCINIA VIRUS ANKARA 08-05-2010
13. 20100183663 INTERGENIC REGIONS AS NOVEL SITES FOR INSERTION OF HIV DNA SEQUENCES IN THE GENOME OF MODIFIED VACCINIA VIRUS ANKARA 07-22-2010
14. 20100183620 COMPOSITIONS AND METHODS FOR REGULATING COLLAGEN AND SMOOTH MUSCLE ACTIN EXPRESSION BY SERPINE2 07-22-2010
15. 20100173388 RECOMBINANT POXVIRUS EXPRESSING HOMOLOGOUS GENES INSERTED INTO THE POXVIRAL GENOME 07-08-2010
16. 20100167332 INDUCTION OF DENDRITIC CELL DEVELOPMENT WITH MACROPHAGE-COLONY STIMULATING FACTOR (M-CSF) 07-01-2010
17. 20100146654 UNACTIVATED OOCYTES AS CYTOPLAST RECIPIENTS FOR NUCLEAR TRANSFER 06-10-2010
18. 20100136054 FLAVIVIRUS NS1 SUBUNIT VACCINE - NS1 proteins or parts thereof of Flaviviruses in particular of Dengue viruses useful for vaccination against said 06-03-2010
19. 20100129404 IMMEDIATE PROTECTION AGAINST PATHOGENS VIA MVA 05-27-2010
20. 20100129326 PURIFICATION OF VACCINIA VIRUS- AND RECOMBINANT VACCINIA VIRUS-BASED VACCINES 05-27-2010
21. 20100119552 PURIFICATION OF VACCINIA VIRUSES USING HYDROPHOBIC INTERACTION CHROMATOGRAPHY 05-13-2010
22. 20100119545 MODIFIED VACCINIA ANKARA VIRUS VARIANT - attenuated virus which is derived from Modified Vaccinia Ankara virus 05-13-2010
23. 20100112001 PURIFICATION OF VACCINIA VIRUS- AND RECOMBINANT VACCINIA VIRUS-BASED VACCINES 05-06-2010
24. 20100086999 DIFFERENTIATION OF PRIMATE PLURIPOTENT CELLS TO HEPATOCYTE-LINEAGE CELLS 04-08-2010
25. 20100048683 MODIFIED VACCINIA VIRUS ANKARA FOR THE VACCINATION OF NEONATES 02-25-2010
26. 20100047871 FUSION PROTEINS OF HIV REGULATORY/ACCESSORY PROTEINS 02-25-2010
27. 20100047280 FLAVIVIRUS NS1 SUBUNIT VACCINE - NS1 proteins or parts thereof of Flaviviruses in particular of Dengue viruses useful for vaccination against said 02-25-2010
28. 20100047268 FUSION PROTEINS OF HIV REGULATORY/ACCESSORY PROTEINS 02-25-2010
29. 20100011451 PHENOTYPIC AND GENOTYPIC DIFFERENCES OF MVA STRAINS 01-14-2010
30. 20090311746 INTERGENIC REGIONS AS INSERTION SITES IN THE GENOME OF MODIFIED VACCINIA VIRUS ANKARA (MVA) 12-17-2009
31. 20090280561 FUSION PROTEIN OF HIV REGULATORY/ACCESSORY PROTEINS 11-12-2009
32. 20090169579 Modified vaccinia Ankara virus avriant - attenuated virus which is derived from Modified Vaccinia Ankara virus 07-02-2009
33. 20090162935 VACCINIA VIRUS HOST RANGE GENES TO INCREASE THE TITER OF AVIPOXVIRUSES 06-25-2009
34. 20090148405 INDUCTION OF DENDRITIC CELL DEVELOPMENT WITH MACROPHAGE-COLONY STIMULATING FACTOR (M-CSF) RECEPTOR LIGANDS 06-11-2009
35. 20090104225 USE OF MVA TO TREAT PROSTATE CANCER - compositions kits and methods for cancer prophylaxis and therapy using recombinant MVA viruses encoding 04-23-2009
36. 20090104224 MODIFIED VACCINIA VIRUS ANKARA FOR THE VACCINATION OF NEONATES 04-23-2009
37. 20090029459 METHOD FOR THE CULTIVATION OF PRIMARY CELLS AND FOR THE AMPLIFICATION OF VIRUSES UNDER SERUM FREE CONDITIONS 01-29-2009
38. 20090017536 MODIFIED VACCINIA ANKARA VIRUS VARIANT AND CULTIVATION METHOD 01-15-2009
39. 20080317778 MODIFIED VACCINIA ANKARA VIRUS VARIANT AND CULTIVATION METHOD 12-25-2008
40. 20080267994 Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF) 10-30-2008
41. 20080267920 MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES 10-30-2008
42. 20080213307 MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES 09-04-2008
43. 20080213302 Methods for treating cancer with MVA - compositions kits and methods for cancer therapy using recombinant MVA viruses encoding a tumor-associated 09-04-2008